Long-term Efficacy and Safety of Piracetam in the Treatment of Progressive Myoclonus Epilepsy
Open Access
- 1 May 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (5) , 781-786
- https://doi.org/10.1001/archneur.58.5.781
Abstract
MYOCLONUS consists of sudden, irregular muscle jerks unassociated with loss of consciousness.1 Progressive myoclonus epilepsy (PME) represents an uncommon epilepsy syndrome caused by a large number of rare specific genetic disorders. In its fully developed form, the syndrome consists of myoclonic jerks, tonic-clonic seizures, mental retardation, and ataxia.2 Myoclonic jerks are often difficult to control in these conditions and usually are an important cause of disability in activities of daily living.Keywords
This publication has 15 references indexed in Scilit:
- Cortical reflex myoclonus in rett syndromeAnnals of Neurology, 1998
- Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placeboJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Commission on Outcome Measurement in Epilepsy, 1994–1997: Final ReportEpilepsia, 1998
- Cortical myoclonus in angelman syndromeAnnals of Neurology, 1996
- Effectiveness of piracetam in cortical myoclonusMovement Disorders, 1993
- Longitudinal EEG Studies in a Kindred with Lafora DiseaseEpilepsia, 1991
- Piracetam in the Treatment of Different Types of MyoclonusClinical Neuropharmacology, 1988
- Therapeutic trial with glycine in myoclonusMovement Disorders, 1988
- Antimyoclonic Action of PiracetamClinical Neuropharmacology, 1986
- THE SPECTRUM OF CORTICAL MYOCLONUS: FROM FOCAL REFLEX JERKS TO SPONTANEOUS MOTOR EPILEPSYBrain, 1985